Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the publication of Phase 1b data evaluating botensilimab (BOT), an Fc-enhanced anti-CTLA-4 antibody, in combination ...
Doctors at Paras Health Gurugram achieved a complex living donor liver transplant on a Liberian patient battling Hepatitis B, ...
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective ...
A new update from the American Gastroenterological Association (AGA) urges stronger prevention efforts and better early-detection tools for hepatocellular carcinoma (HCC), the leading cause ...
Hepatic arterial infusion chemotherapy combined with donafenib and tislelizumab versus transcatheter chemoembolization alone for hepatocellular carcinoma: A propensity score matching study.
Advocacy and persistence are crucial in navigating healthcare, especially when initial diagnoses are inconclusive or dismissed. Misconceptions about HCC often lead to stigma, but early detection can ...
Most patients were male (85.3%), with a median age of 72 years. Liver cirrhosis was present in 70.6%, and 77% had Barcelona Clinic Liver Cancer stage C. Immunotherapy was predominantly first-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results